Skip to main content

Advertisement

SpringerLink
Log in

Non-damaging retinal laser therapy in chronic central serous chorioretinopathy

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the functional and anatomical outcomes of non-damaging retinal laser therapy (NRT), in cases with chronic central serous chorioretinopathy (CSCR).

Methods

Twenty-three eyes of 23 treatment-naïve chronic CSCR patients were included in this study. The irradiation of 577 nm yellow light was conducted on the serous detachment area after switching over to the NRT algorithm. Anatomical and functional changes after treatments were investigated.

Results

The mean age of the subjects was 48.68 ± 5.93 years (41–61). The mean best-corrected visual acuity (BCVA) and the mean central macular thickness (CMT) values were 0.42 ± 0.12logMAR (0.20–0.70) and 315.69 ± 61.25 µm (223–444) before NRT; and 0.28 ± 0.11logMAR (0.10–0.50) and 223.26 ± 60.91 µm (134–336) at the 2nd month follow-up visit (p < 0.001, for both). At the 2nd-month follow-up visit after NRT, complete resorption of subretinal fluid was observed in 18 eyes (78.3%) and incomplete resorption in five eyes (21.7%). Worse values of BCVA and CMT before NRT were found as increased risk for incomplete resorption (p = 0.002 and ρ = 0.612 for BCVA, and p < 0.001 and ρ = 0.715 for CMT).

Conclusion

Significant functional and anatomical improvements can be observed in the early period after NRT in patients with chronic CSCR. Patients having worse baseline BCVA and CMT have increased risk for incomplete resorption.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bujarborua D (2001) Long-term follow-up of idiopathic central serous chorioretinopathy without laser. Acta Ophthalmol Scand 79:417–421

    Article  CAS  PubMed  Google Scholar 

  2. Wang M, Munch IC, Hasler PW et al (2008) Central serous chorioretinopathy. Acta Ophthalmol 86:126–145

    Article  PubMed  Google Scholar 

  3. Bouzas EA, Karadimas P, Pournaras CJ (2002) Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 47:431–448

    Article  PubMed  Google Scholar 

  4. Nicholson B, Noble J, Forooghian F et al (2013) Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 58:103–126

    Article  PubMed  PubMed Central  Google Scholar 

  5. Yannuzzi LA (1987) Type-A behavior and central serous chorioretinopathy. Retina 7:111–131

    Article  CAS  PubMed  Google Scholar 

  6. Wong KH, Lau K, Chhablani J et al (2016) Central serous chorioretinopathy: what we have learned so far. Acta Ophthal 94:321–325

    Article  Google Scholar 

  7. van Dijk EHC, Fauser S, Breukink MB et al (2018) Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial. Ophthalmology 125:1547–1555

    Article  PubMed  Google Scholar 

  8. van Rijssen TJ, van Dijk EHC, Yzer S et al (2019) Central serous chorioretinopathy: towards an evidence-based treatment guideline. Prog Retin Eye Res 73:100770

    Article  PubMed  Google Scholar 

  9. Ross A, Ross AH, Mohamed Q (2011) Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol 22:166–173

    Article  PubMed  Google Scholar 

  10. Yannuzzi LA (2010) Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 149:361–363

    Article  PubMed  Google Scholar 

  11. Chan WM, Lai TY, Lai RY et al (2008) Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 28:85–93

    Article  PubMed  Google Scholar 

  12. Maruko I, Iida T, Sugano Y et al (2010) Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 117:1792–1799

    Article  PubMed  Google Scholar 

  13. Yadav NK, Jayadev C, Mohan A et al (2015) Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome. Eye 29:258–264

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Mainster MA (1999) Decreasing retinal photocoagulation damage: principles and techniques. Semin Ophthalmol 14:200–209

    Article  CAS  PubMed  Google Scholar 

  15. Koytak A, Erol K, Coskun E et al (2010) Fluorescein angiography guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy. Retina 30:1698–1703

    Article  PubMed  Google Scholar 

  16. Kim SW, Oh J, Oh IK et al (2009) Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging 40:300–303

    Article  CAS  PubMed  Google Scholar 

  17. Abouammoh MA (2015) Advances in the treatment of central serous chorioretinopathy. Saudi J Ophthalmol 29:278–286

    Article  PubMed  PubMed Central  Google Scholar 

  18. Lavinsky D, Wang J, Huie P et al (2016) Nondamaging retinal laser therapy: rationale and applications to the macula. Invest Ophthalmol Vis Sci 57:2488–2500

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sramek C, Paulus Y, Nomoto H et al (2009) Dynamics of retinal photocoagulation and rupture. J Biomed Opt 14:034007

    Article  PubMed  Google Scholar 

  20. Lavinsky D, Sramek C, Wang J et al (2014) Subvisible retinal laser therapy: titration algorithm and tissue response. Retina 34:87–97

    Article  PubMed  Google Scholar 

  21. Sramek C, Mackanos M, Spitler R et al (2011) Non-damaging retinal phototherapy: dynamic range of heat shock protein expression. Invest Ophthalmol Vis Sci 52:1780–1787

    Article  CAS  PubMed  Google Scholar 

  22. Yenari MA, Liu J, Zheng Z et al (2005) Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection. Ann N Y Acad Sci 1053:74–83

    Article  CAS  PubMed  Google Scholar 

  23. Schwartz R, Habot-Wilner Z, Martinez MR, Nutman A et al (2017) Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study. Acta Ophthalmol 95:610–618

    Article  Google Scholar 

  24. Luttrull JK, Chang DB, Margolis BWL et al (2015) Laser resensitization of medically unresponsive neovascular age-related macular degeneration. Retina 35:1184–1194

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Tayfur Ata Sokmen Medicine Faculty, Hatay Mustafa Kemal University, Merkez Mah. Tayfur Sokmen Cad. No: 36, 31080, Antakya/Hatay, Turkey

    Cagri Ilhan

  2. Department of Ophthalmology, University of Health Sciences, Etlik City Education and Research Hospital, Ankara, Turkey

    Mehmet Citirik & Mesut Özdemir

Authors
  1. Cagri Ilhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehmet Citirik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mesut Özdemir
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

CI, MC, MO wrote the main manuscript text and prepared figures. All authors reviewed the manuscript

Corresponding author

Correspondence to Cagri Ilhan.

Ethics declarations

Competing interests

The authors declare no competing interests.

Conflict of interest

Author Cagri Ilhan declares that he has no conflict of interest. Author Mehmet Citirik declares that she has no conflict of interest. Author Mesut Ozdemir declares that he has no conflict of interest.

Human and animals rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ilhan, C., Citirik, M. & Özdemir, M. Non-damaging retinal laser therapy in chronic central serous chorioretinopathy. Int Ophthalmol 43, 2875–2882 (2023). https://doi.org/10.1007/s10792-023-02691-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-023-02691-5

Keywords

Search

Navigation